TRIAL OF PREDNISOLONE FOR PREVENTION OF MELARSOPROL-INDUCED ENCEPHALOPATHY IN GAMBIENSE SLEEPING SICKNESS
Authors:
- 1 June 1989
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 333 (8649) , 1246-1250
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- DIFLUOROMETHYLORNITHINE FOR ARSENO-RESISTANT TRYPANOSOMA BRUCEI GAMBIENSE SLEEPING SICKNESSThe Lancet, 1987
- Clinical and Pathological Aspects of Human African Trypanosomiasis (T. B. Gambiense) with Particular Reference to Reactive Arsenical EncephalopathyThe American Journal of Tropical Medicine and Hygiene, 1986
- HUMAN AFRICAN TRYPANOSOMIASIS (T.b. GAMBIENSE): A STUDY OF 16 FATAL CASES OF SLEEPING SICKNESS WITH SOME OBSERVATIONS ON ACUTE REACTIVE ARSENICAL ENCEPHALOPATHYNeuropathology and Applied Neurobiology, 1986
- The trypanosomiases.BMJ, 1985
- EXISTING CHEMOTHERAPY AND ITS LIMITATIONSBritish Medical Bulletin, 1985
- Treatment of gambiense sleeping sickness in the Sudan with oral DFMO (DL-α-difluoromethylornithine), an inhibitor of ornithine decarboxylase; first field trialTransactions of the Royal Society of Tropical Medicine and Hygiene, 1985
- Present status of chemotherapy and chemoprohylaxis of human trypanosomiasis in the Eastern HemispherePharmacology & Therapeutics, 1980
- Immunosuppression in Gambian trypanosomiasisTransactions of the Royal Society of Tropical Medicine and Hygiene, 1973
- Effects of Cortisone Upon the Course of Infection ofTrypanosoma Gambiense, T. Rhodesiense, T. BruceiandT. Congolensein Albino RatsPathogens and Global Health, 1964